A Study of Language Interpretation Solutions for People With Breast Cancer

Recruiting N/A Interventional Study
Breast Cancer Breast Cancer Stage II Breast Cancer Stage III
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
700 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Phase I Patients * Age \>=18 years (per EMR) * Preferred language for healthcare is Spanish or Mandarin (per self-report) * Limited English Proficient; cannot speak English "very well" (per self-report) * Diagnosis of breast cancer or gastrointestinal (per EMR) * Will be visiti…
Contacts

Francesca Gany, MD, MS

646-888-8054

ganyf@mskcc.org

CONTACT

Lisa Diamond, MD

646-888-8061

diamondl@mskcc.org

CONTACT